质子中心介绍
山东省质子中心（山东省肿瘤医院质子临床研究中心）由省、市共建共享，是济南国际医学科学中心“一号工程”、“引爆项目”，项目总投资14.7亿元，占地60亩，总建筑面积8.8万平方米，主体21层，包括300张病床，中日韩肿瘤研究院和放射免疫研究等7个中心，以及人才培养、培训和国际会议中心等。
山东省质子中心于2018年7月18日正式开工，从提交申请到正式开工仅用了短短的132天，梦想照进现实；2019年以全国第一名获得质子设备配置证；2021年4月1日，质子中心正式启用，从开工建设到投入使用仅用了两年半时间；质子治疗系统用最短时间通过了国家质子设备辐射安全许可证现场检查，并于2022年7月6日正式获得国家生态环境部审批，被业界评价为“创造了想都不敢想的奇迹”；2023年11月1日获得国家医疗器械注册证，正式投入临床，建设速度创造了“世界之最”。是首台获批的采用超导回旋加速器技术和360度旋转机架的质子治疗系统，可以实现多角度治疗。在保证患者治疗效果的前提下，能够有效缩短患者治疗时间，成为了解除肿瘤患者病痛的一大利器，让老百姓在家门口就能享受到国际最尖端的放疗技术。
目前质子中心二期工程重离子中子项目也在快速推进中，继续由省市共建共享，重离子设备获批配置证，并完成招标采购和预付款，随着重离子项目的开工建设，山东省肿瘤医院将成为国际上唯一一家同时拥有质子和重离子两套治疗系统的医院。我们将立足山东、引领全国、面向东北亚，让省内外的肿瘤患者在国内就能享受到国际上最高端的肿瘤治疗技术和更高质量、更高水平、更高层次的医疗服务；同时借助质子、重离子、中子三驾马车，率先打造国际最顶级的肿瘤放疗中心，实现放疗学科五年内国际领先的宏伟目标。
Proton Center Introduction
Shandong Proton Center is one part of Shandong Cancer Hospital and Institute, Shandong First Medical University, who provides radiotherapy services to cancer patients in the eastern region of China and other province. It located at 2999 Yantai Avenue, Jinan, Shandong Province, China, serving as a “No.1 Project”, "Ignition Project" within the Jinan International Medical Science Center. With a total investment of 1.47 billion yuan, spanning 60 acres and boasting a total floor area of 88,000 square meters across 21 floors, including 300 beds, this state-of-the-art facility comprises seven specialized centers. Among them are the Sino-Japanese-Korean Cancer Research Institute and the Radiation Immunology Research Center, alongside facilities dedicated to talent cultivation, training, international conferences and so on.
Commencing construction on July 18, 2018, the Shandong Proton Center transitioned swiftly from application submission to ground-breaking, achieving this milestone in a mere 132 days—a testament to turning dreams into tangible realities. In 2019, it clinched the first place nationwide for proton equipment configuration certification. Fast forward to April 1, 2021, when the Proton Center was officially inaugurated, marking a remarkable journey from construction initiation to operational readiness in just two and a half years. Demonstrating unprecedented efficiency, the proton therapy system passed national proton equipment radiation safety license in record time and received official approval from the Ministry of Ecology and Environment on July 6, 2022—a feat hailed by industry insiders as "a miracle beyond imagination." By November 1, 2023, it had obtained the National Medical Device Registration Certificate, paving the way for its formal clinical debut and the construction speed created "The World's Greatest ". It is the first approved proton therapy system to employ superconducting cyclotron technology and a 360-degree rotating gantry. The proton therapy system can achieve multi-angle therapy and effectively shorten the treatment time of patients, under the premise of ensuring the treatment effect of patients. It has become a major tool to relieve the pain of tumor patients, so that people can be served by the most advanced international radiotherapy technology at their doorstep. Since Nov.20th 2023 to Mar.20th 2024, 240 patients have been treated by proton system during this 4 months. There are about more than 80 patients will be treated per day in three gantry rooms.
Presently, the heavy ion neutron project of the second phase of the Proton Center is also rapidly advancing, continuing to be co-built and shared by provinces and cities, and heavy ion equipment has approved configuration certificate. The heavy ion neutron project has completed bidding and procurement and advance payment. With the construction of the heavy ion project, Shandong Cancer Hospital will become the only hospital internationally with proton and heavy ion two sets of treatment systems. We will be based in Shandong, lead the country and face Northeast Asia, enable cancer patients inside and outside the province can enjoy the highest international tumor treatment technology and higher quality, higher level and higher standards of medical services at home. At the same time, with the help of protons, heavy ions and neutrons, we will take the lead in building the world's top tumor radiotherapy center and achieve the ambitious goal of international leadership in radiotherapy discipline within five years.
